Levamisole treatment for children with steroid sensitive nephrotic syndrome. A multi-centre, double-blind, placebo-controlled, randomised trial

Trial Profile

Levamisole treatment for children with steroid sensitive nephrotic syndrome. A multi-centre, double-blind, placebo-controlled, randomised trial

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Levamisole (Primary)
  • Indications Nephrotic syndrome
  • Focus Registrational; Therapeutic Use
  • Sponsors Ace Pharmaceuticals
  • Most Recent Events

    • 19 Dec 2013 According to an Ace Pharmaceuticals media release, Professor Jean Claude Davin and pediatrician Mariken Gruppen of the AMC (Academic Medical Center, Amsterdam) were acting as principal investigator (JCD) and study coordinator.
    • 19 Dec 2013 According to an Ace Pharmaceuticals media release, database lock date of this study was 19th December 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top